These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 9828831)
1. Regulation of the Wilms' tumour suppressor (WT1) gene by an antisense RNA: a link with genomic imprinting? Ward A; Dutton JR J Pathol; 1998 Aug; 185(4):342-4. PubMed ID: 9828831 [TBL] [Abstract][Full Text] [Related]
2. Identification of an antisense WT1 promoter in intron 1: implications for WT1 gene regulation. Malik KT; Wallace JI; Ivins SM; Brown KW Oncogene; 1995 Oct; 11(8):1589-95. PubMed ID: 7478583 [TBL] [Abstract][Full Text] [Related]
3. Aberrant imprinting of the insulin-like growth factor II receptor gene in Wilms' tumor. Xu YQ; Grundy P; Polychronakos C Oncogene; 1997 Mar; 14(9):1041-6. PubMed ID: 9070652 [TBL] [Abstract][Full Text] [Related]
4. Genomic imprinting at the WT1 gene involves a novel coding transcript (AWT1) that shows deregulation in Wilms' tumours. Dallosso AR; Hancock AL; Brown KW; Williams AC; Jackson S; Malik K Hum Mol Genet; 2004 Feb; 13(4):405-15. PubMed ID: 14681303 [TBL] [Abstract][Full Text] [Related]
5. The imprinted antisense RNA at the Igf2r locus overlaps but does not imprint Mas1. Lyle R; Watanabe D; te Vruchte D; Lerchner W; Smrzka OW; Wutz A; Schageman J; Hahner L; Davies C; Barlow DP Nat Genet; 2000 May; 25(1):19-21. PubMed ID: 10802648 [TBL] [Abstract][Full Text] [Related]
6. Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor. Vu TH; Chuyen NV; Li T; Hoffman AR Cancer Res; 2003 Apr; 63(8):1900-5. PubMed ID: 12702581 [TBL] [Abstract][Full Text] [Related]
7. Antisense WT1 transcription parallels sense mRNA and protein expression in fetal kidney and can elevate protein levels in vitro. Moorwood K; Charles AK; Salpekar A; Wallace JI; Brown KW; Malik K J Pathol; 1998 Aug; 185(4):352-9. PubMed ID: 9828833 [TBL] [Abstract][Full Text] [Related]
8. Imprinted expression of the canine IGF2R, in the absence of an anti-sense transcript or promoter methylation. O'Sullivan FM; Murphy SK; Simel LR; McCann A; Callanan JJ; Nolan CM Evol Dev; 2007; 9(6):579-89. PubMed ID: 17976054 [TBL] [Abstract][Full Text] [Related]
9. Imprinting of the murine MAS protooncogene is restricted to its antisense RNA. Alenina N; Bader M; Walther T Biochem Biophys Res Commun; 2002 Jan; 290(3):1072-8. PubMed ID: 11798184 [TBL] [Abstract][Full Text] [Related]
10. Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1. Sim EU; Smith A; Szilagi E; Rae F; Ioannou P; Lindsay MH; Little MH Oncogene; 2002 May; 21(19):2948-60. PubMed ID: 12082525 [TBL] [Abstract][Full Text] [Related]
11. Neuron-specific relaxation of Igf2r imprinting is associated with neuron-specific histone modifications and lack of its antisense transcript Air. Yamasaki Y; Kayashima T; Soejima H; Kinoshita A; Yoshiura K; Matsumoto N; Ohta T; Urano T; Masuzaki H; Ishimaru T; Mukai T; Niikawa N; Kishino T Hum Mol Genet; 2005 Sep; 14(17):2511-20. PubMed ID: 16037066 [TBL] [Abstract][Full Text] [Related]
12. Allelic IGF2R repression does not correlate with expression of antisense RNA in human extraembryonic tissues. Oudejans CB; Westerman B; Wouters D; Gooyer S; Leegwater PA; van Wijk IJ; Sleutels F Genomics; 2001 May; 73(3):331-7. PubMed ID: 11350125 [TBL] [Abstract][Full Text] [Related]
13. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells. Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727 [TBL] [Abstract][Full Text] [Related]
14. High frequency of loss of allelic integrity at Wilms' tumor suppressor gene-1 locus in advanced breast tumors associated with aggressiveness of the tumor. Gupta S; Joshi K; Wig JD; Arora SK Indian J Cancer; 2009; 46(4):303-10. PubMed ID: 19749460 [TBL] [Abstract][Full Text] [Related]
15. De novo methylation at intronic CpG islands of Igf2r is associated with decreased expression of antisense RNA in aged mice. Yang IC; Yang SK; Park CW; Chung JH Biochem Biophys Res Commun; 2000 Aug; 274(3):722-6. PubMed ID: 10924343 [TBL] [Abstract][Full Text] [Related]
16. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy. Perugorria MJ; Castillo J; Latasa MU; Goñi S; Segura V; Sangro B; Prieto J; Avila MA; Berasain C Cancer Res; 2009 Feb; 69(4):1358-67. PubMed ID: 19190340 [TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1. Zaia A; Fraizer GC; Piantanelli L; Saunders GF Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720 [TBL] [Abstract][Full Text] [Related]
18. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1. Zhang X; Xing G; Saunders GF Anticancer Res; 1999; 19(3A):1641-8. PubMed ID: 10470095 [TBL] [Abstract][Full Text] [Related]
19. Lack of reciprocal genomic imprinting of sense and antisense RNA of mouse insulin-like growth factor II receptor in the central nervous system. Hu JF; Balaguru KA; Ivaturi RD; Oruganti H; Li T; Nguyen BT; Vu TH; Hoffman AR Biochem Biophys Res Commun; 1999 Apr; 257(2):604-8. PubMed ID: 10198258 [TBL] [Abstract][Full Text] [Related]
20. Promoter-restricted histone code, not the differentially methylated DNA regions or antisense transcripts, marks the imprinting status of IGF2R in human and mouse. Vu TH; Li T; Hoffman AR Hum Mol Genet; 2004 Oct; 13(19):2233-45. PubMed ID: 15294879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]